Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VIROPHARMA INC Financial Overview

  • Income Statement: VPHM

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 232.31 M 203.77 M 28.54 M 12.28%
    Gross Profit 212.62 M 188.72 M 23.91 M 11.24%
    Net Income Before Extra Items/Preferred Div 67.62 M 95.35 M -27.74 M -41.02%
    Operating Income 80.92 M 115.80 M -34.88 M -43.10%
  • Cash Flow: VPHM

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -10.07 M 221.47 M -231.54 M 2,299.31%
    Net Cash Flow - Investing -15.44 M 216.18 M -231.62 M 1,500.10%
    Net Cash Flow/Operating Activities 91.44 M 122.87 M -31.43 M -34.37%
  • Balance Sheet: VPHM

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 1.05 B 763.75 M 289.93 M 27.52%
    Total Liabilities 392.66 M 267.19 M 125.47 M 31.95%
    Shareholders Equity 661.02 M 496.56 M 164.46 M 24.88%
  • Key Ratios / Statistics: VPHM

    • Valuation

      Price/Earnings (TTM) 15.69
      Price/Sales (TTM) 4.80
      Price/Book (MRQ) 1.01
      Price/Cash Flow (TTM) 6.55
    • Profitability

      Gross Margin 91.53
      Operating Margin 34.83
      Profit Margin 29.11
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 6.85
      Current Ratio (MRQ) 10.04
      Long Term Debt-to-Equity (MRQ) 18.60
    • Management Effectiveness

      Return on Equity (TTM) 9.61
      Return on Assets (TTM) -1.84
      Return on Investments (TTM) 8.62